Related Experiment Video
Updated: Mar 19, 2026
14:24
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
12.3K
Cancer Therapy-Related Cardiac Dysfunction: Unresolved Issues.
1Baker-IDI Heart and Diabetes Institute, Melbourne, Australia.
The Canadian Journal of Cardiology
|June 26, 2016
Summary
Cardio-oncology addresses heart failure from cancer treatments. Further research is crucial to understand cardiotoxicity, improve screening, and guide long-term patient care for cancer survivors.
Area of Science:
- Cardiology
- Oncology
- Cardio-oncology
Background:
- Cancer therapies like chemotherapy and radiotherapy can cause cardiac failure.
- An aging population undergoing cancer treatment increases the risk of heart failure.
- Cardio-oncology is an emerging subspecialty addressing these concerns.
Purpose of the Study:
- To discuss six critical unresolved issues in cardio-oncology requiring further research.
- To highlight the need for a better understanding of cardiotoxicity and its management.
Main Methods:
- This article reviews and discusses key challenges in the field.
- It focuses on identifying areas for future research and evidence development.
Main Results:
- Six key research questions in cardio-oncology are identified:
- 1. Frequency of overt heart failure from cardiotoxicity.
- 2. Optimal diagnostic strategies for cardiotoxicity.
- 3. Improved risk prediction models.
- 4. Alternatives to ejection fraction for evaluation.
- 5. Best cardioprotective strategies.
- 6. Evidence-based algorithms for long-term follow-up.
Conclusions:
- Addressing these research gaps will enhance understanding of cardiotoxicity magnitude.
- This will inform screening protocols, cardioprotective therapy decisions, and long-term follow-up strategies for cancer survivors.
More Related Videos
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
725
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
725
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
636
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
636
01:29Cardiomyopathy VI: Nursing Management
442
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
442
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
732
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
732
01:26Imbalances in Cardiac Output
3.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
01:26Heart Failure Drugs: Inotropic Agents
1.8K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.8K